Intravenous liposomal irinotecan in metastatic triple-negative breast cancer after ≥ 2 prior lines of chemotherapy: a phase Ib study.
Fan Y, Zhang Q, Yan M, Qu X, Yin Y, Sun T, Yang J, Wang Y, Wang X, Niu Z, Wang X, Sun S, Zhao W, Liu Y, Niu M, Zhao X, Xu B.
Fan Y, et al. Among authors: qu x.
Nat Commun. 2025 Jan 2;16(1):3. doi: 10.1038/s41467-024-55090-4.
Nat Commun. 2025.
PMID: 39746964
Free PMC article.
Clinical Trial.